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Background: Recently, internet-based interventions have been proposed as effective treatments for people with
panic disorder (PD). However, little is known about the clinical effects of integrating mobile technology into these
interventions. Because users carry their smartphones with them throughout the day, we hypothesize that this
technology can be used to significantly support individuals with monitoring and overcoming their PD symptoms.
The aim of the present study is to evaluate the efficacy and cost-effectiveness of a newly developed hybrid
intervention that combines internet/PC with smartphone delivery to treat the symptoms of PD. The intervention is
based on cognitive behavioral therapy and consists of six modules over a total of six weeks.
Methods/Design: A two-arm randomized controlled trial (RCT) will be conducted to evaluate the effects of a hybrid
online training module for PD. Based on a power calculation (d =0.60; 1-β of 80%; α =0.05), 90 participants with
mild to moderate panic symptoms with or without agoraphobia (as assessed by the Panic and Agoraphobia Scale)
will be recruited from the general population and randomly assigned to either the intervention group or a
six-month waitlist control group. The primary outcome measure will be the severity of panic symptoms. Secondary
outcomes will include depression, quality of life, and an observer-based rating of panic severity. Furthermore, data
regarding acceptance and the usability of the smartphone app will be assessed. Assessments will take place at
baseline as well as eight weeks, three months, and six months after randomization. Moreover, a cost-effectiveness
analysis will be performed from a societal perspective. Data will be analyzed on an intention-to-treat basis and
per protocol.
Discussion: To our knowledge, this RCT is one of the first to examine the efficacy of a hybrid online training for
adult PD. This study seeks to contribute to the emerging field of hybrid online training. If the intervention is
efficacious, then research on this hybrid online training should be extended. The cost-effectiveness analysis will also
indicate whether online training is an economical tool for treating PD among adults.
Trial registration: German Clinical Trial Register: DRKS00005223 (registered on 15 August 2013).
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Panic disorder (PD) is characterized by recurrent, unex-
pected panic attacks and a persistent worry about future
panic attacks [1]. With a 12-month prevalence of 1.8%
among adults, PD is one of the most common anxiety
disorders [2]. In addition, sub-threshold cases have been
estimated to be even more prevalent, with between 10
and 16% of the population experiencing a panic attack at
some point during their lifetimes [3]. PD (with or with-
out agoraphobia) is associated with a high psychiatric
comorbidity, lower quality of life, and severe work im-
pairment [4,5], and also places a significant burden on
healthcare systems [2,6].
Psychotherapeutic treatments such as cognitive beha-
vioral therapy (CBT) are effective for PD [7]. However,
only 16.7% of people who suffer from anxiety disorders
seek help from a mental health professional, and of these
individuals, only 21.3% receive CBT, which is arguably
the most effective treatment [8]. The reasons for this
low endorsement of effective PD treatments include a
lack of psychoeducation, a fear of stigmatization, and
structural barriers such as a lack of access to adequate
treatments [9,10].
Interventions delivered via the internet have been pro-
posed as a helpful method to overcome such barriers
and facilitate access to empirically validated treatments
[11,12]. Although internet-based interventions based on
CBT are effective at treating adult PD [13-16], one draw-
back of this method (compared with traditional face-to-
face treatments) is the lack of direct support from a
therapist throughout the course of treatment, particu-
larly during exposure exercises. This lack of direct sup-
port from a therapist might increase the risk of clients
not fully complying with the treatment, or dropping out
of treatment completely. Studies that evaluate online
trainings with self-exposure elements consistently report
particularly high dropout rates [17,18].
One potentially promising method to enhance the ad-
herence to, and efficacy of, internet-based interventions
for PD might be to complement interventions with com-
ponents that are delivered through clients’ smartphones.
Mobile components might assist patients in overcoming
several limitations of traditional desktop- and laptop-
based interventions. For example, these barriers might
include situations in which the clients start to engage in
exposure exercises in their natural environment (as is
typical for in vivo exposure exercises) and are subse-
quently required to leave their desktop PCs or laptop.
This results in a dilemma - either exposure exercises are
exclusively conducted at the client’s desk or they are
conducted without the device and therefore lack support
during the exposure exercises. Consequently, clients are
more likely to disengage from the intervention. In con-
trast, clients often carry their smartphones with them inalmost any situation, and they might support clients in
successfully completing the intended exposure exercise
[19-21]. Moreover, when desktop PCs or laptops are
used to monitor symptoms of PD to identify factors that
cue panic attacks and avoidance, clients typically use
daily or weekly electronic diary entries, which are likely
biased by memory effects because clients must complete
these diaries retrospectively and not in real-time [22-28].
In contrast, a mobile-based PD intervention tool can be
used to assess the symptoms of PD in real-time through
ecological momentary assessment (EMA) approaches
[29-33]. Finally, a PC-based program can only prompt
appropriate coping responses when the PC is on and
clients are near it. Therefore, it is not available in other
situations of their daily lives in which they inevitably
encounter stimuli that trigger the symptoms of PD. In
contrast, a mobile device that is nearly always on, or near,
the client can be used as an ecological mobile intervention
(EMI) device and prompt coping responses, potentially
those that have been specifically identified as effective for
the individual based on the EMA function of the device.
Despite these advantages, no data are currently available
regarding the efficacy of online-based interventions for
PD that integrate a mobile component.
We developed the GET.ON PANIC intervention for
adult PD. This intervention integrates desktop and mo-
bile components into a hybrid online intervention based
on CBT for PD. The desktop component is primarily
used to provide text- and video-based psychoeducation,
as well as exercises that require participants to write ex-
tensive texts (for example, in a cognitive restructuring
module), which is difficult to do on smartphones. The
mobile component is used to guide clients through self-
monitoring and self-exposure tasks. To evaluate the effi-
cacy and cost-effectiveness of GET.ON PANIC, we will
conduct a randomized controlled trial (RCT).
Methods/Design
Study design
We will conduct an RCT with two arms: an internet-
based self-help intervention supported by a mobile ap-
plication with minimal guidance from a coach (GET.ON
PANIC), and a waitlist control group who will receive
the intervention after a six-month follow-up assessment.
Assessments will be conducted prior to randomization, at
post-treatment (eight weeks), as well as at the three- and
six-month follow-up assessments (see Figure 1). The Ethi-
cal Committee of Marburg approved this study (number:
2013-23 K), and it was registered with the German Clini-
cal Trial Register (registration number: DRKS00005223).
Study population
The study population will consist of a community sam-
ple of adults who suffer from mild to moderate panic
Figure 1 Overview of study procedure. BDI-II, Beck Depression Inventory II; PAS, Panic and agoraphobia scale; SCID-I, Structured clinical
interview for DSM-IV Axis I Disorders.
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periencing mild to moderate panic symptoms as assessed
by the Panic and Agoraphobia Scale (PAS, score range: 9
to 28) [34,35], being 18 years or older, having panic as
the primary concern for seeking help, and having in-
ternet and smartphone access. Although both iOS™ and
Android™ devices will be supported, the GET.ON PANIC
APP will not run on entry-level smartphones with small
screens and low memories. Therefore, the minimum sys-
tem requirements are an iPhone™ 3GS or a comparable
Android device. With respect to the operating system,
iOS 6, iOS 7, and Android 2.3 or newer will be sup-
ported. Furthermore, because the mobile application
periodically uploads data to our servers, we recommend
that participants have a data plan to avoid unnecessarycosts. The exclusion criteria for this study are the fol-
lowing: experiencing too mild (PAS score 0 to 8) or too
severe (PAS score 29 to 52) panic symptoms; receiving
current psychological help for anxiety problems or being
on a waitlist for psychotherapy; having physical health
problems assessed via self-report that prevents partici-
pants from engaging in self-exposure, as recommended by
an established German guideline for treating people with
PD and agoraphobia [36]; currently having posttraumatic
stress disorder or psychotic or dissociative disorders as-
sessed via self-report and clinical interview; and having
current suicidality, as measured by a score above 1 on
item 9 of the Beck Depression Inventory II (BDI-II)
[37,38] and question A9 of the Structured Clinical Inter-
view for DSM-IV Axis I Disorders (SCID-I) [39]. In the
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suicidal ideation or intention, the exclusion procedure will
be managed as determined by an established suicide pro-
tocol. All excluded participants will be contacted via email
and provided with information regarding where they can
obtain appropriate help.
Sample size
The sample size for this study is based on the meta-
analysis of self-help treatments for anxiety disorders by
Haug et al. [13]. An effect size of d =0.83 was derived
for PD after comparing the self-help group with the
waitlist/placebo group. Because hybrid online training
was not integrated into the meta-analysis, we chose a
conservative estimation of d =0.60. To examine the effi-
cacy of GET.ON PANIC with a two-tailed t-test (α =0.05;
1-β =0.80), a sample of 45 participants will be needed for
each group. Thus, the total sample size for this study will
be 90 participants.
Randomization
We will use the computer program DatInf RandList
Version 1.2 (DatInf GmbH, Tübingen, Germany) [40] to
randomize participants into either the intervention
group or the waitlist control condition. This random as-
signment will be stratified for clinical or subclinical
symptomatology, as well as the presence or absence of
agoraphobia.
Procedure
Participants will be recruited from the general popu-
lation via an online health center website postings in
anxiety- and panic-related online forums, and newspaper
articles about the research project. Participants will re-
ceive an email with detailed information about the study.
Afterwards, participants will be invited to complete a
screening questionnaire to evaluate their study eligibility.
Participants will then have access to the online training
platform via their email address (as their username) and
a self-selected password. If participants meet the eligibil-
ity criteria, they will receive an ID number. Participants
can then opt into study participation by reading, signing,
and returning the informed consent document. Partici-
pants will then receive a link to complete the baseline
questionnaires. After completing the baseline question-
naires (t0), participants will be invited to take part in a
telephone interview. This interview has two purposes.
The first is for a trained interviewer to conduct a diag-
nostic interview (SCID-I) to provide a detailed sample
description [41,42]. The second is to conduct an obser-
ver rating of anxiety symptoms using the Hamilton Anx-
iety Scale (HAM-A) [43] to strengthen the robustness of
the self-report measures. Assessors blind to the partici-
pant treatment condition will conduct all observer-basedratings. The post-treatment measurement (t1) will be as-
sessed eight weeks after randomization. Follow-up mea-
sures will be conducted at three months (t2) and six
months (t3) after randomization. All questionnaires at
the baseline, post- and follow-up assessments are self-
reported and conducted via the internet, with the excep-
tion of the observer rating HAM-A, which will be per-
formed at t0 and t1 via telephone. The waitlist control
group will receive the treatment after t3.
Intervention
GET.ON PANIC is a hybrid internet-based self-help in-
tervention with minimal therapeutic guidance based on
CBT principles [18,44-46]. The hybrid online training
consists of two components: a browser-based section
(desktop PC or laptop) and a mobile application (smart-
phone app). The intervention is divided into six mod-
ules: psychoeducation, interoceptive exposure, in vivo
exposure, two modules of cognitive restructuring, and
relapse prevention (see Table 1). Using responsive web
design, participants can use the program on a desktop
PC, a laptop, a tablet, or a smartphone. An integrated
read-aloud function allows participants to follow the les-
sons via audio narration. The app addresses interocep-
tive and in vivo exercises as well as diary and relaxation
exercises. Detailed information about the development
of the app can be found in the paper by Kleine Stege-
mann et al. [47].In the first module, participants will re-
ceive an overview of the different modules and the
practical procedure of the online training. Information
about PD will be provided, and personal goals will be de-
fined. In addition, a mobile diary will be introduced to
the participants. The emphasis of the second module is
interoceptive exposure. The theoretical background of
the relationship between bodily symptoms and anxiety
will be provided in an interactive way with videos and
writing exercises. The app contains three interoceptive
exposure packages, each consisting of four different tasks.
In module three, participants will rank their individual
anxiety provoking situations in a hierarchy before begin-
ning the app-assisted in vivo exposures (see Figure 2). In
addition, participants will continue with the second of the
interceptive exposure exercises, which address dizziness.
The fourth module concerns cognitive restructuring.
Participants will deal with the maladaptive relationships
among situations, cognitions, and emotions. In addition,
participants will continue with interoceptive and in vivo
exposures. In module five, participants will engage in ad-
vanced cognitive restructuring, where they analyze their
thinking patterns, identify their cognitive distortions and
thinking errors, challenge their thoughts associated with
panic, and replace their maladaptive thoughts with more
constructive cognitions. Participants will continue to prac-
tice interoceptive and in vivo exposures for homework.
Table 1 Overview of sessions
Week Content and homework
1 Browser: Psychoeducation:
Information about panic
Defining goals of training
Setting up a reward list
Mobile: Daily diary
Registration of current panic event (event-based)
Daily summary of panic, avoidance, and mood
2 Browser: Interoceptive exposure:
Bodily symptoms in panic
Avoidance
Safety behaviors
Mobile: Respiratory interoceptive exposure exercises
Daily diary
3 Browser: In vivo exposure:
Defining an anxiety hierarchy
Mobile: In vivo exposures
Dizziness interoceptive exposure exercises
Daily diary
4 Browser: Cognitive restructuring I:
Negative automatic thoughts
Defining anxiety project (training schedule for
exposures)
Mobile: In vivo exposures
Further interoceptive exposure exercises
Daily diary
5 Browser: Cognitive restructuring II:
Reality testing of automatic negative thoughts
Mobile: In vivo exposures
Further interoceptive exposure exercises
Daily diary
6 Browser: Relapse prevention:
Early warning signs
Critical life events
Evaluation of training and its aims
Mobile: Breathing and muscle relaxation exercises
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vention. Participants will have the opportunity to reflect,
summarize, and evaluate the online training as well as
their progress toward achieving their predefined goals.
Participants will work towards coping prior to experien-
cing anxiety-provoking events that might occur in the fu-
ture by making two plans: one to identify early warning
signs and one for dealing with difficult life circumstances.
Furthermore, participants will be trained in breathing andmuscle relaxation exercises to learn adequate coping strat-
egies for daily stressors. Audio-based relaxation exercises
will be available to the participants in both short and long
formats on the app.
Throughout the study, participants will receive online
technical support from an IT specialist to install the app,
access to a personal online coach (a trained psychologist)
to answer any questions, reminder messages for home-
work assignments, and brief homework feedback from the
online coach based on a manual written by the first author
(LE). All online coaches will receive online training with
regard to GET.ON PANIC by the first and second authors
(LE and SKSt), and will be supervised by licensed and ex-
perienced psychotherapists when offering guidance. The
total amount of coaching time per participant will be ap-
proximately three hours for the duration of the six-week
online training.
Instruments
For an overview of the instruments at screening, base-
line, after treatment, and at the follow-up assessments,
see Table 2.
Screening and diagnostic interview
The preliminary screening will collect demographic data
from participants, including their age, gender, education,
therapeutic experience, and medication use, and the PAS
will be administered (for a detailed description see the
section regarding the primary outcome measure) [34,35].
Item 9 of the BDI-II [37,38] will be used to screen for
suicidality. The BDI-II is a 21-item assessment of de-
pressive symptoms that has demonstrated high internal
consistency using outpatient samples [37].
The SCID-I [39] will be used to assess the presence of
PD, agoraphobia, other anxiety disorders, and current
depressive episodes. A trained interviewer will perform
the interview via telephone. Previous studies have




The primary outcome will be the severity of panic and
agoraphobia symptoms as assessed by the total PAS
score [34,35,48]. This questionnaire was originally devel-
oped as a self- and observer-rating scale. In this study,
we will use the self-rating questionnaire that was adap-
ted into an online version. The PAS consists of 13 items
grouped into five subscales, and an extra item regarding
unexpected versus expected panic attacks. The five sub-
scales assess the following areas: panic attacks, agorapho-
bic avoidance, anticipatory anxiety, daily life limitations,
and health concerns (for example, the fear of physical
harm or the fear of an organic cause). These subscales can
Figure 2 App screenshots of GET.ON PANICAPP. The app supports in vivo exposures. Participants start with ranking their anxiety provoking
situations in a hierarchical order. Furthermore, they are asked to answer questions about their anxiety before and after performing the exposure
exercise (for example the level of anxiety, the degree of avoidance and the severity of body symptoms). In addition, they have the ability to take
a photo after an in vivo exposure exercise is completed. The bar chart in the end offers graphical feedback to the participants regarding the
exposure performance.
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all subscales, ranging from 0 to 52 points. A higher score
on the PAS indicates more panic symptoms. The psycho-
metric properties of the scale are satisfactory, with a Cron-
bach’s alpha of 0.86 [49]. A score of between 0 and 8
indicates no clinically relevant symptoms, scores of be-
tween 9 and 28 indicate moderate symptoms, and a score
of 29 or higher indicates a severe level of symptoms [49].Table 2 Overview of instruments per time of assessment
Assessments
Sociodemographic data
Suicidality (Item 9, BDI-II)
Diagnosis (SCID-I, sections for anxiety disorders and current depressive episo
Panic and agoraphobia severity, self-rating (PAS)





Quality of life (EQ-5D, SF-12)
Economic evaluations (TiC-P)
Negative effects of online health trainings
Attitudes towards seeking psychological help
User satisfactory
Technology acceptance of smartphone app
Usability of smartphone app (SUS)
T0 = Baseline, T1 = 8 weeks, T2 = 3 months, T4 = 6 months.
Assessments: x = intervention and control group, (x) = intervention group only.
ACQ, Agoraphobic cognitions questionnaire; BDI-II, Beck Depression Inventory II; BS
depression scale; EQ-5D, EuroQol; HAM-A, Hamilton anxiety scale; MI, Mobility inven
DSM-IV Axis I Disorders; SF-12, Short form 12; SUS, System Usability Scale; TiC-P, Tri
for Psychiatry.Secondary outcome measures
Depression
Depressive symptoms will be measured using the Allge-
meine Depressions-Skala (ADS) [50], the German adapta-
tion of the Center for Epidemiological Studies Depression
Scale (CES-D) [51]. The ADS consists of 20 items that
refer to the previous week and are answered using a four-
point Likert scale. The total score ranges from 0 to 60. ItsScreening T0 T1 T2 T3
x - - - -
x - - - -
de) - x - -
x x x x x
- x x - -
- x x x x
- x x x x
- x x x x
- x x x x
- x x x x
- x - - x
- - (x) (x) (x)
- - (x) - -
- - (x) - -
- - (x) - -
- - (x) - -
Q, Body sensations questionnaire; CES-D, Center for epidemiological studies
tory; PAS, Panic and agoraphobia scale; SCID-I, Structured clinical interview for
mbos and the Institute of Medical Technology Assessment Cost Questionnaire
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is r =0.91 [50].Quality of life
Quality of life will be measured using the EuroQol
(EQ-5D) [52] and the Short Form 12 (SF-12) [53]. The
EQ-5D is a well-established measurement of quality of
life that consists of five items assessing mobility, self-
care, common activities, pain and/or discomfort, and
anxiety and/or depression, as well as a visual analogue
scale concerning health status. We will also use the
SF-12, which consists of 12 items that assess eight
health domains: physical functioning, role limitations,
pain, general health perception, vitality, mental health,
emotional role, and social functioning. The SF-12 ge-
nerates two summary scores: physical health and mental
health.Agoraphobic cognitions
Agoraphobic cognitions will be measured using the
Agoraphobic Cognitions Questionnaire (ACQ) [54,55].
The ACQ consists of 14 items, and its total score ranges
from 14 to 70. Craske et al. reported that the ACQ has
an internal reliability of α =0.80 [56].Bodily sensations
The Body Sensation Questionnaire (BSQ) [54,55] is a
17-item self-report questionnaire that measures bodily
sensations. The BSQ ranges from 17 to 85 points and
has a satisfactory internal reliability of α =0.87 [54].Agoraphobic avoidance
The Mobility Inventory (MI) [54,55] measures agorapho-
bic avoidance. The MI consists of 27 items that address
the most important agoraphobic situations. Each item is
rated both for when patients are alone and when they
are accompanied. These two scales have a summed score
ranging from 27 to 135 points, respectively. The in-
ternal consistencies are α =0.94 (alone) and α =0.91
(accompanied) [57].Observer rating anxiety symptoms
In addition, the secondary outcome measures will in-
clude the observer-rated HAM-A [43,58] to obtain a
more detailed understanding of symptom severity. The
HAM-A is a 14-item clinician-reported rating scale with
a total score ranging from 0 to 30. Thus, we will use the
structured interview guide for the HAM-A (SIGH-A)
[59]. The interview has shown satisfactory inter-rater and
test-retest reliabilities of Intraclass Correlation Coefficients
of respectively 0.99 and 0.89 [59].Economic evaluation
We will use an adaption of the Trimbos/iMTA question-
naire to measure the costs associated with psychiatric ill-
ness (TiC-P) [60] with regard to the German healthcare
system.
Diary data
EMA data will be collected via the mobile application
GET.ON PANIC APP [47]. This app contains a diary
where clients can record their panic attacks and monitor
their progress using daily summaries. With regard to the
latter, clients will summarize their general anxiety levels,
their degree of avoidance, and their moods each evening.
The application also records the type and number of ex-
posure exercises performed by the client.
Additional measures
We will also collect data concerning technology ac-
ceptance (via a questionnaire based on the technology
acceptance model; TAM) [61,62], the usability of the
smartphone app GET.ON PANIC APP (via the System
Usability Scale; SUS) [63,64], user satisfaction of the on-
line training (a self-designed questionnaire based on the
German version of the Client Satisfaction Questionnaire
[65,66], and the adverse effects of psychotherapy [67].
Statistical analyses
The analyses will be performed based on the Consoli-
dated Standards of Reporting Trials (CONSORT) state-
ment regarding eHealth [68]. The data will be analyzed
on an intention-to-treat basis. We will also conduct per
protocol and completers-only investigations as second-
ary analyses.
Treatment efficacy
Group differences in the baseline values of the primary
outcome will be compared using t-tests to assess whe-
ther randomization was successful. Missing data will be
addressed following the recommendations of Little and
Rubin [69] and Schafer [70]. We will analyze the PAS
data at eight weeks post-treatment using between-group
analyses of covariance with regard to the individual
baseline PAS scores, adjusted for sex, age, and socio-
economic status. We will use Cohen’s d to measure the
between-group effect size. Cohen’s d will be calculated
as the difference between the mean post-test scores of
the intervention group and the control group divided by
the pooled standard deviation [71]. All other secondary
outcomes will be analyzed in a similar manner.
We will also conduct clinical significance change ana-
lyses as described by Jacobson and Truax [72]. In the
first step, we will test whether the changes from pre-test
to post-test are statistically reliable and build a reliable
change index (RCI). In the second step, we will calculate
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who display a reliable positive change, no change, or a
reliable deteriorated change will be classified as re-
sponders, non-responders, or deteriorated, respectively
[72]. We will use mixed-model regressions to examine
the long-term effect on the primary outcome after three
and six months.
Economic analyses
We will conduct an economic evaluation by performing
a cost-effectiveness analysis (CEA) and a cost-utility
analysis (CUA) from a societal perspective. The clinical
outcome of the CEA will be the severity of panic symp-
toms as assessed by the PAS. Quality-adjusted life
years (QALYs) will be calculated for the CUA. A non-
parametric bootstrapping method with 95% confidence in-
tervals will be used to assess the differences between the
intervention and control groups. The intervention and
waitlist control groups will be compared in terms of in-
cremental costs and incremental effects. Thus, we will
calculate the incremental cost-effectiveness ratio (ICER).
Bootstrapping via 5,000 iterations will be used to quantify
the uncertainty in the ratios and to test the robustness
of the ICER. The results will be displayed on a cost-
effectiveness plane and via a cost-effective acceptability
curve. A multi-way sensitivity analysis will be con-
ducted to test the robustness of the base-case findings.
For instance, these analyses will integrate data based on
the EMA to reduce the retrospective bias of self-
reported panic symptom severity.
Discussion
Given the availability and the daily use of smartphones,
mobile-based health interventions have become increas-
ingly popular [73-78]. Evidence for the efficacy of these
studies comes from attempts to promote physical ac-
tivity [79], cope with schizophrenia [25], and overcome
child anxiety [80]. Despite the obvious advantages of in-
tegrating mobile components into online-based treat-
ments (for example, mobile components can be used for
EMA, supporting exposure exercises away from home,
and EMI), no data are available regarding the efficacy of
such an intervention for PD. Thus, we developed the hy-
brid online training GET.ON PANIC based on CBT, and
we will test the efficacy and cost-effectiveness of this on-
line training among people with clinical or subclinical
PD with or without agoraphobia at post-assessment, as
well as at three- and six-month follow-ups, compared
with a waitlist control group who will receive the online
training after the last assessment, but who will have free
access to the usual treatments.
This study has several limitations. First, the absence
of an active control group does not allow us to clarify
the mechanisms responsible for changes in treatment.However, because this study is one of the first to test
the efficacy of hybrid online training for PD, evaluating
the efficacy of the intervention is an important research
question in and of itself. If the present study provides
evidence regarding the efficacy of GET.ON PANIC,
then future research should detect the mechanisms that
drive the change within the intervention. Such research
should also include dismantling studies that compare
online-based interventions with or without a mobile com-
ponent to explain the additional benefits of including a
mobile component. Second, using a waitlist control group
design does not enable a comparison between newly
developed hybrid online training and the current gold
standard (face-to-face CBT to treat people with PD and
agoraphobia). Future studies should compare hybrid
online training with the gold standard. Finally, this
study is not designed to test the long-term efficacy of
GET.ON PANIC. With an assessment time of six months,
we will only be able to make conclusions over a relatively
short period of time. A 12-month follow-up assessment is
desirable.
Trial status
The study is currently ongoing. Recruitment began in
August 2013 and will conclude in October 2014.
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